OPENING OF ECHOLIGHT USA
Echolight announces the opening of a new corporate office in the United States. A steady growth over the years has favored the expansion of the innovative Italian company in many countries of the world, thanks to the numerous certifications obtained for the marketing of its products, with the support of a solid network of partners specialized in the sale of medical devices for the bone health. A further milestone has recently been reached, the establishment of an Echolight branch in New York City, a new reference center for all specialists in the sector in the United States.
Another important step forward, after obtaining approval from the FDA – U.S. Food & Drug Administration. Every year in America there are millions of citizens suffering from Osteoporosis, a silent disease widespread in particular among the adult population, as in menopausal women, exposed to a significant decrease in bone mass with a relative increase in the risk of fracture.
Echolight’s innovative densitometer with R.E.M.S. technology (Radiofrequency Echographic Multi Spectrometry) is unique in its kind: the device performs non-invasive echographic scans, free of ionizing radiation, which assess the bone internal micro-architecture for an accurate and repeatable clinical evaluation in the short and long term. In this way, doctors and operators in the sector are able to make an early diagnosis to prevent the onset of the disease and constant monitoring the bone health status.
Hundreds of Clinical Centers, Universities and Hospitals all over the world have chosen the Italian device for their clinical applications, but also for scientific studies and research.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.